Abstract LB-A23: Discovery of a potent catalytic p300/CBP inhibitor that targets lineage-specific tumors
Bromberg, Kenneth D., Lasko, Loren M., Jakob, Clarissa G., Qiu, Wei, Montgomery, Debra, Digiammarino, Enrico L., Hansen, Todd M., Risi, Roberto M., Frey, Robin R., Manaves, Vlasios, Shaw, Bailin, Algire, Mikkel, Hessler, Paul, Lam, Lloyd T., Uziel, Tamar, Favire, Emily, Ferguson, Debra, Buchanan, Fritz G., Martin, Ruth L., Torrent, Maricel, Rosenberg, Saul H., Michaelides, Michael R., Lai, Albert
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article